On the difference between 0.5-M and 1.0-M gadolinium chelates for 3D MR angiography
- PMID: 15457997
- DOI: 10.1007/s10406-004-0050-0
On the difference between 0.5-M and 1.0-M gadolinium chelates for 3D MR angiography
Similar articles
-
Whole-body CE-MRA with Gadovist.Eur Radiol. 2004 May;14 Suppl 5:M26-7. doi: 10.1007/s10406-004-0052-y. Eur Radiol. 2004. PMID: 15457999 No abstract available.
-
Contrast-enhanced three-dimensional pulmonary perfusion magnetic resonance imaging: intraindividual comparison of 1.0 M gadobutrol and 0.5 M Gd-DTPA at three dose levels.Invest Radiol. 2004 Mar;39(3):143-8. doi: 10.1097/01.rli.0000101482.79137.f4. Invest Radiol. 2004. PMID: 15076006 Clinical Trial.
-
Pulmonary CE-MR angiography and perfusion imaging.Eur Radiol. 2004 May;14 Suppl 5:M32-3. doi: 10.1007/s10406-004-0055-8. Eur Radiol. 2004. PMID: 15458002 No abstract available.
-
Contrast-enhanced MR angiography.Abdom Imaging. 1998 Sep-Oct;23(5):469-84. doi: 10.1007/s002619900384. Abdom Imaging. 1998. PMID: 9841060 Review.
-
Extracardiac applications of MR blood pool contrast agent in children.Pediatr Radiol. 2014 Dec;44(12):1598-609; quiz 1595-7. doi: 10.1007/s00247-014-3167-x. Epub 2014 Nov 19. Pediatr Radiol. 2014. PMID: 25408135 Review.
Cited by
-
Total-body 3D magnetic resonance angiography influences the management of patients with peripheral arterial occlusive disease.Eur Radiol. 2006 Mar;16(3):685-91. doi: 10.1007/s00330-005-0001-8. Epub 2005 Sep 21. Eur Radiol. 2006. PMID: 16175353
MeSH terms
Substances
LinkOut - more resources
Full Text Sources